Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
32
BRSL Quote, Financials, Valuation and Earnings
Last price:
$14.40
Seasonality move
:
3.84%
Day range:
$14.39 - $14.72
52-week range:
$13.81 - $24.13
Dividend yield:
5.55%
P/E ratio:
10.01x
P/S ratio:
1.02x
P/B ratio:
1.78x
Volume:
2.7M
Avg. volume:
2.4M
1-year change:
-33.23%
Market cap:
$2.9B
Revenue:
$2.5B
EPS (TTM):
--
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $4.1B | $2.6B | $2.5B | $2.5B | |
| Revenue Growth (YoY) | -22.72% | 31.23% | -36.49% | -2.62% | -0.67% | |
| Cost of Revenues | $2B | $2.1B | $1.4B | $1.3B | $1.3B | |
| Gross Profit | $1.1B | $2B | $1.2B | $1.2B | $1.2B | |
| Gross Profit Margin | 36.46% | 47.89% | 46.09% | 47.85% | 46.5% | |
| R&D Expenses | $191M | $238M | $45M | $37M | $45M | |
| Selling, General & Admin | $707M | $810M | $400M | $407M | $393M | |
| Other Inc / (Exp) | -$683M | -$38M | $239M | -$70M | $2M | |
| Operating Expenses | $902M | $1B | $448M | $444M | $443M | |
| Operating Income | $234M | $909M | $749M | $766M | $725M | |
| Net Interest Expenses | $398M | $342M | $216M | $207M | $205M | |
| EBT. Incl. Unusual Items | -$848M | $529M | $772M | $488M | $521M | |
| Earnings of Discontinued Ops. | $37M | $415M | -$146M | $43M | $238M | |
| Income Tax Expense | $28M | $274M | $212M | $223M | $250M | |
| Net Income to Company | -$802M | $1.1B | $560M | $264M | $270M | |
| Minority Interest in Earnings | -$59M | -$188M | -$139M | -$151M | -$160M | |
| Net Income to Common Excl Extra Items | -$898M | $482M | $275M | $156M | $348M | |
| Basic EPS (Cont. Ops) | -$4.39 | $2.35 | $1.36 | $0.78 | $1.73 | |
| Diluted EPS (Cont. Ops) | -$4.39 | $2.33 | $1.35 | $0.77 | $1.71 | |
| Weighted Average Basic Share | $204.7M | $205M | $202M | $200M | $202M | |
| Weighted Average Diluted Share | $204.7M | $207M | $203M | $203M | $204M | |
| EBITDA | $341M | $1.4B | $1.4B | $1.1B | $1.1B | |
| EBIT | -$435M | $884M | $996M | $705M | $735M | |
| Revenue (Reported) | $3.1B | $4.1B | $2.6B | $2.5B | $2.5B | |
| Operating Income (Reported) | $234M | $909M | $749M | $766M | $725M | |
| Operating Income (Adjusted) | -$435M | $884M | $996M | $705M | $735M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.1B | $1.1B | $661M | $583M | |
| Revenue Growth (YoY) | 24.69% | 3.55% | 0.95% | -37.7% | -11.8% | |
| Cost of Revenues | $514M | $550M | $525M | $330M | $327M | |
| Gross Profit | $501M | $501M | $536M | $331M | $256M | |
| Gross Profit Margin | 49.36% | 47.67% | 50.52% | 50.08% | 43.91% | |
| R&D Expenses | $55M | $57M | $62M | $11M | $11M | |
| Selling, General & Admin | $186M | $193M | $217M | $102M | $104M | |
| Other Inc / (Exp) | $120M | $6M | -$30M | $7M | -$37M | |
| Operating Expenses | $241M | $250M | $279M | $113M | $118M | |
| Operating Income | $260M | $251M | $257M | $218M | $138M | |
| Net Interest Expenses | $94M | $76M | $69M | $54M | $46M | |
| EBT. Incl. Unusual Items | $287M | $182M | $155M | $173M | $56M | |
| Earnings of Discontinued Ops. | $11M | -- | -- | $13M | $52M | |
| Income Tax Expense | $148M | $65M | $87M | $57M | $48M | |
| Net Income to Company | $138M | $117M | $67M | $115M | $8M | |
| Minority Interest in Earnings | -$57M | -$38M | -$44M | -$47M | -$33M | |
| Net Income to Common Excl Extra Items | $92M | $79M | $23M | $82M | $27M | |
| Basic EPS (Cont. Ops) | $0.45 | $0.39 | $0.12 | $0.41 | $0.13 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.39 | $0.11 | $0.40 | $0.13 | |
| Weighted Average Basic Share | $204.9M | $203.7M | $200M | $200M | $202M | |
| Weighted Average Diluted Share | $206.5M | $205.2M | $202M | $203M | $202M | |
| EBITDA | $574M | $433M | $410M | $328M | $207M | |
| EBIT | $388M | $261M | $228M | $229M | $105M | |
| Revenue (Reported) | $1B | $1.1B | $1.1B | $661M | $583M | |
| Operating Income (Reported) | $260M | $251M | $257M | $218M | $138M | |
| Operating Income (Adjusted) | $388M | $261M | $228M | $229M | $105M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.1B | $2.6B | $3B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2B | $2.2B | $1.4B | $1.6B | $1.6B | |
| Gross Profit | $1.3B | $2B | $1.2B | $1.4B | $1.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $185M | $240M | $49M | $90M | $87M | |
| Selling, General & Admin | $729M | $817M | $424M | $511M | $497M | |
| Other Inc / (Exp) | -$333M | -$154M | $203M | -$34M | -$70M | |
| Operating Expenses | $917M | $1.1B | $476M | $601M | $591M | |
| Operating Income | $414M | $900M | $756M | $844M | $722M | |
| Net Interest Expenses | $392M | $323M | $209M | $233M | $219M | |
| EBT. Incl. Unusual Items | -$313M | $424M | $745M | $579M | $433M | |
| Earnings of Discontinued Ops. | $34M | $404M | -- | $14M | $277M | |
| Income Tax Expense | $177M | $191M | $235M | $222M | $269M | |
| Net Income to Company | -$417M | $1.1B | $510M | $312M | $163M | |
| Minority Interest in Earnings | -$102M | -$169M | -$145M | -$154M | -$146M | |
| Net Income to Common Excl Extra Items | -$558M | $470M | $219M | $214M | $294M | |
| Basic EPS (Cont. Ops) | -$2.72 | $2.30 | $1.10 | $1.07 | $1.46 | |
| Diluted EPS (Cont. Ops) | -$2.73 | $2.29 | $1.08 | $1.05 | $1.44 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $871M | $1.3B | $1.5B | $1.4B | $1.1B | |
| EBIT | $101M | $760M | $963M | $824M | $664M | |
| Revenue (Reported) | $3.3B | $4.1B | $2.6B | $3B | $2.9B | |
| Operating Income (Reported) | $414M | $900M | $756M | $844M | $722M | |
| Operating Income (Adjusted) | $101M | $760M | $963M | $824M | $664M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.1B | $1.1B | $661M | $583M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $514M | $550M | $525M | $330M | $327M | |
| Gross Profit | $501M | $501M | $536M | $331M | $256M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $55M | $57M | $62M | $11M | $11M | |
| Selling, General & Admin | $186M | $193M | $217M | $102M | $104M | |
| Other Inc / (Exp) | $120M | $6M | -$30M | $7M | -$37M | |
| Operating Expenses | $241M | $250M | $279M | $113M | $118M | |
| Operating Income | $260M | $251M | $257M | $218M | $138M | |
| Net Interest Expenses | $94M | $76M | $69M | $54M | $46M | |
| EBT. Incl. Unusual Items | $287M | $182M | $155M | $173M | $56M | |
| Earnings of Discontinued Ops. | $11M | -- | -- | $13M | $52M | |
| Income Tax Expense | $148M | $65M | $87M | $57M | $48M | |
| Net Income to Company | $138M | $117M | $67M | $115M | $8M | |
| Minority Interest in Earnings | -$57M | -$38M | -$44M | -$47M | -$33M | |
| Net Income to Common Excl Extra Items | $92M | $79M | $23M | $82M | $27M | |
| Basic EPS (Cont. Ops) | $0.45 | $0.39 | $0.12 | $0.41 | $0.13 | |
| Diluted EPS (Cont. Ops) | $0.44 | $0.39 | $0.11 | $0.40 | $0.13 | |
| Weighted Average Basic Share | $204.9M | $203.7M | $200M | $200M | $202M | |
| Weighted Average Diluted Share | $206.5M | $205.2M | $202M | $203M | $202M | |
| EBITDA | $574M | $433M | $410M | $328M | $207M | |
| EBIT | $388M | $261M | $228M | $229M | $105M | |
| Revenue (Reported) | $1B | $1.1B | $1.1B | $661M | $583M | |
| Operating Income (Reported) | $260M | $251M | $257M | $218M | $138M | |
| Operating Income (Adjusted) | $388M | $261M | $228M | $229M | $105M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $907M | $591M | $590M | $508M | $584M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1B | $1.1B | $811M | $404M | $468M | |
| Inventory | $169M | $183M | $254M | $110M | $113M | |
| Prepaid Expenses | $39M | $54M | $44M | $45M | $45M | |
| Other Current Assets | $55M | $25M | $37M | $42M | $49M | |
| Total Current Assets | $3.4B | $2.5B | $2.1B | $2.1B | $6.2B | |
| Property Plant And Equipment | $1.5B | $1.4B | $1.3B | $799M | $767M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.7B | $4.7B | $4.5B | $2.7B | $2.7B | |
| Other Intangibles | $3B | $2.5B | $2.3B | $795M | $567M | |
| Other Long-Term Assets | $103M | $66M | $75M | $4B | $51M | |
| Total Assets | $13B | $11.3B | $10.4B | $10.5B | $10.3B | |
| Accounts Payable | $1.1B | $1B | $731M | $643M | $718M | |
| Accrued Expenses | $256M | $175M | $160M | $132M | $117M | |
| Current Portion Of Long-Term Debt | $393M | $52M | $61M | -- | $208M | |
| Current Portion Of Capital Lease Obligations | $44M | $39M | $37M | $22M | $24M | |
| Other Current Liabilities | $475M | $148M | $238M | $654M | $1.4B | |
| Total Current Liabilities | $2.6B | $1.9B | $1.8B | $1.7B | $2.7B | |
| Long-Term Debt | $7.9B | $6.5B | $5.7B | $5.7B | $5.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11.4B | $9.4B | $8.5B | $8.5B | $8.2B | |
| Common Stock | $20M | $21M | $21M | $21M | $21M | |
| Other Common Equity Adj | $330M | $412M | $529M | $521M | $516M | |
| Common Equity | $777M | $1.3B | $1.4B | $1.4B | $1.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $784M | $689M | $550M | $510M | $409M | |
| Total Equity | $1.6B | $2B | $2B | $2B | $2.1B | |
| Total Liabilities and Equity | $13B | $11.3B | $10.4B | $10.5B | $10.3B | |
| Cash and Short Terms | $907M | $591M | $590M | $508M | $584M | |
| Total Debt | $8.3B | $6.5B | $5.8B | $5.7B | $5.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $748M | $600M | $669M | $377M | $631M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $912M | $714M | $705M | $723M | $432M | |
| Inventory | $167M | $208M | $294M | $321M | $113M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $489M | $594M | $460M | $404M | $124M | |
| Total Current Assets | $3.3B | $2.9B | $2.3B | $1.9B | $6.2B | |
| Property Plant And Equipment | $1.4B | $1.3B | $1.3B | $1.2B | $794M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4.7B | $4.4B | $4.5B | $4.5B | $2.7B | |
| Other Intangibles | $1.5B | $1.4B | $1.3B | $1.5B | $86M | |
| Other Long-Term Assets | $1.6B | $1.4B | $1.1B | $923M | $578M | |
| Total Assets | $12.6B | $11.2B | $10.5B | $10.1B | $10.3B | |
| Accounts Payable | $1.2B | $783M | $835M | $733M | $688M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $375M | -- | $272M | $721M | $216M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $978M | $1.2B | $874M | $982M | $1.6B | |
| Total Current Liabilities | $2.6B | $2B | $2.2B | $2.4B | $2.5B | |
| Long-Term Debt | $7.4B | $6.4B | $5.5B | $4.8B | $5.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11B | $9.4B | $8.6B | $8.3B | $8.3B | |
| Common Stock | $20M | -- | $21M | $21M | $21M | |
| Other Common Equity Adj | $292M | -- | $524M | $529M | $512M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $714M | $521M | $450M | $354M | $353M | |
| Total Equity | $1.5B | $1.8B | $1.9B | $1.9B | $2B | |
| Total Liabilities and Equity | $12.6B | $11.2B | $10.5B | $10.1B | $10.3B | |
| Cash and Short Terms | $748M | $600M | $669M | $377M | $631M | |
| Total Debt | $7.8B | $6.5B | $5.8B | $5.5B | $5.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$802M | $1.1B | $560M | $264M | $270M | |
| Depreciation & Amoritzation | $776M | $526M | $419M | $415M | $402M | |
| Stock-Based Compensation | -$7M | $35M | $34M | $34M | $38M | |
| Change in Accounts Receivable | $74M | -$95M | $114M | -$55M | -$85M | |
| Change in Inventories | $17M | -$13M | -$17M | -$21M | -$5M | |
| Cash From Operations | $866M | $978M | $899M | $1B | $1B | |
| Capital Expenditures | $255M | $238M | $162M | $147M | $149M | |
| Cash Acquisitions | -- | -- | $476M | -- | -- | |
| Cash From Investing | -$269M | $636M | $168M | -$393M | -$357M | |
| Dividends Paid (Ex Special Dividend) | -$41M | -$41M | -$161M | -$160M | -$161M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $750M | $1.3B | $72M | $609M | $556M | |
| Long-Term Debt Repaid | -$984M | -$2.9B | -$597M | -$801M | -$675M | |
| Repurchase of Common Stock | -- | -$41M | -$115M | -- | -- | |
| Other Financing Activities | -$127M | -$292M | -$210M | -$253M | -$240M | |
| Cash From Financing | -$438M | -$1.9B | -$1.1B | -$638M | -$586M | |
| Beginning Cash (CF) | $894M | $1.1B | $808M | $740M | $739M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $182M | -$284M | $2M | $10M | $87M | |
| Ending Cash (CF) | $1.1B | $808M | $740M | $739M | $775M | |
| Levered Free Cash Flow | $611M | $740M | $737M | $893M | $881M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$39M | $34M | $90M | $98M | -- | |
| Depreciation & Amoritzation | $189M | $170M | $179M | $256M | -- | |
| Stock-Based Compensation | $7M | $12M | $12M | $13M | -- | |
| Change in Accounts Receivable | -$48M | $102M | $38M | $69M | -- | |
| Change in Inventories | $1M | -$28M | -$25M | $9M | -- | |
| Cash From Operations | $254M | $196M | $34M | $343M | -- | |
| Capital Expenditures | $73M | $80M | $99M | $150M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $677M | -$77M | -$99M | -$97M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$40M | -$40M | -$80M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $87M | $212M | $81M | -- | -- | |
| Long-Term Debt Repaid | -$1.1B | -$52M | -$7M | $29M | -- | |
| Repurchase of Common Stock | -- | -$15M | -- | -- | -- | |
| Other Financing Activities | -$80M | -$120M | -$121M | -$113M | -- | |
| Cash From Financing | -$1.1B | -$3M | -$140M | -$171M | -- | |
| Beginning Cash (CF) | $956M | $685M | $805M | $497M | -- | |
| Foreign Exchange Rate Adjustment | $23M | -$49M | -$1M | -$13M | -- | |
| Additions / Reductions | -$160M | $116M | -$205M | $74M | -- | |
| Ending Cash (CF) | $819M | $743M | $599M | $558M | -- | |
| Levered Free Cash Flow | $181M | $116M | -$65M | $193M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$417M | $1.1B | $510M | $312M | $163M | |
| Depreciation & Amoritzation | $770M | $512M | $429M | $332M | $405M | |
| Stock-Based Compensation | $10M | $41M | $35M | $32M | $36M | |
| Change in Accounts Receivable | -$291M | -$44M | $117M | -$68M | $11M | |
| Change in Inventories | $36M | -$42M | -$30M | $15M | -$2M | |
| Cash From Operations | $924M | $952M | $1B | $849M | $1.1B | |
| Capital Expenditures | $218M | $263M | $183M | $88M | $190M | |
| Cash Acquisitions | -- | -- | $476M | -- | -- | |
| Cash From Investing | -$237M | $625M | $139M | -$385M | -$390M | |
| Dividends Paid (Ex Special Dividend) | -- | -$82M | -$160M | -$120M | -$201M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $834M | $190M | $431M | $217M | -- | |
| Long-Term Debt Repaid | -$2B | -$1.5B | -$1.1B | -$419M | -$932M | |
| Repurchase of Common Stock | -- | -$80M | -- | -- | -- | |
| Other Financing Activities | -$236M | -$290M | -$243M | -$320M | -$176M | |
| Cash From Financing | -$1.4B | -$1.7B | -$1.1B | -$737M | -$403M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$689M | -$151M | $63M | -$271M | $340M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $706M | $689M | $838M | $761M | $944M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $99M | $151M | $157M | $213M | $8M | |
| Depreciation & Amoritzation | $375M | $342M | $361M | $355M | $102M | |
| Stock-Based Compensation | $11M | $22M | $23M | $22M | $7M | |
| Change in Accounts Receivable | -$134M | $67M | $6M | $24M | $51M | |
| Change in Inventories | $5M | -$53M | -$63M | $7M | $1M | |
| Cash From Operations | $469M | $385M | $345M | $463M | $224M | |
| Capital Expenditures | $121M | $153M | $193M | $185M | $76M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $626M | -$139M | -$190M | -$180M | -$116M | |
| Dividends Paid (Ex Special Dividend) | -- | -$81M | -$80M | -$80M | -$40M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | $245M | $473M | -- | $540M | |
| Long-Term Debt Repaid | -$2.5B | -$52M | -$470M | -$52M | -$338M | |
| Repurchase of Common Stock | -- | -$54M | -- | -- | -- | |
| Other Financing Activities | -$154M | -$192M | -$226M | -$285M | -$108M | |
| Cash From Financing | -$1.4B | -$134M | -$303M | -$433M | -$79M | |
| Beginning Cash (CF) | $2.1B | $1.5B | $1.5B | $1.2B | $775M | |
| Foreign Exchange Rate Adjustment | -$13M | -$62M | $7M | -$31M | $19M | |
| Additions / Reductions | -$297M | $112M | -$148M | -$150M | $29M | |
| Ending Cash (CF) | $1.8B | $1.4B | $1.4B | $1.1B | $823M | |
| Levered Free Cash Flow | $348M | $232M | $152M | $278M | $148M | |
Get BRSL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BRSL
Sector
P/E ratio
10.01x
16.92x
PEG ratio
0.27x
0.17x
P/B ratio
1.78x
1.42x
Price / LTM sales
1.02x
0.68x
Growth Metrics
BRSL
Sector
Revenue growth
--
0.64%
Earnings growth
--
-1.02%
Revenue (5-year growth)
-9.03%
3.61%
Earnings forecast
$0.25
$0.24
Profitability
BRSL
Sector
Profitability FY 2024
$1.2B
$456.7M
Return on invested capital
--
4.58%
Return on assets
--
2.72%
Return on equity
--
6.7%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Aug
12
Balance Sheet
BRSL
Sector
Total cash
--
$139.6M
Short term investments
--
$46.8M
Total assets
$10.3B
$1.4B
Long term debt
--
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
